Takeda Pharma to Buy Rare Disease Drugmaker Shire for $62 Billion
09 May, 2018, 00:36 | Author: Lora Ball
In one of the biggest deals in the pharmaceutical industry's history and the biggest worldwide takeover by a Japanese company, Takeda Pharmaceutical today struck a deal to buy its larger Irish rival Shire Plc for $62 billion (£46 billion).
Shares in Takeda closed up 3.99 percent at 4,638 yen just before the announcement, which had been widely expected, while in London trade Shire was up 4.77 percent at £40.40.
In a separate statement, it said it would fund the deal with a bridge loan facility of almost $31 billion.
Takeda has focused on developing and commercialising innovative therapies that address unmet clinical needs in gastroenterology, oncology and neuroscience plus vaccines.
In particular, Shire will give Takeda access to research and development in fields the Japanese firm has long sought, including digestive systems, mental illness and rare diseases.
If he gets past that hurdle Weber will then need to knit together a new top 10 - by sales - global pharma company while carving out $1.4 billion in cost synergies. The companies expect the deal to close in the first half of 2019.
As part of the merger agreement, Shire shareholders will be entitled to receive $30.33 in cash for each Shire share owned and 0.839 shares either 0.839 new Takeda shares or 1.678 new Takeda ADSs, according to Takeda.
Takeda said it represents a premium of around 64% compared with the price of its shares in late March, when rumours of Takeda's interest began to swirl.
Takeda has not decided whether to keep the headquarters in the northern suburb after it completes one of the biggest deals in the history of the pharmaceutical industry.
The acquisition is expected to become effective in the first half of next year, it said.
Takeda, like many Japanese companies, been expanding overseas to compensate for slowing growth at home.
Takeda, which has seen its market value slide to US$34 billion since announcing its interest, is taking over a much bigger rival.
"Shire's highly complementary product portfolio and pipeline, as well as experienced employees, will accelerate our transformation for a stronger Takeda", Christophe Weber, Takeda's chief executive officer, said in a statement.
In a separate statement today, Takeda said it will continue to focus on growing its oncology portfolio, which along with its hematology holdings expanded a year ago when Takeda acquired Ariad Pharmaceuticals for $5.2 billion.
Mohammed Ali, 30, driving his scooter to the seashore, stated he isn't voting as a result of there aren't any decisions. Voters will select one checklist of allied candidates, in addition to a most popular candidate from amongst them.
When it became clear that we could sell him in the window then we had to do the deal and find other solutions. For Liverpool , Adam Lallana is back in training but unlikely to be available from the start.
The farmers, he said , were suffering because of the policies of successive Congress governments at the Centre and in the state. Trying to hit hard Congress, Chouhan said that Madhya Pradesh was in shambles in Congress rule in the year 2003.
Dorsey may not be finished though, as Jamar Taylor 's name appeared in a recent column from Cleveland.com's Terry Pluto . The only other quarterback in rookie minicamp is Joel Stave, a well-traveled practice squad player.
Meghan's mum Doria Ragland will travel with her daughter to the chapel where her dad, Thomas Markle, will walk her down the aisle. There had been speculation that Thomas Markle wouldn't attend because of Meghan's estrangement from that side of the family.
You will also have to copy the message from the Pastebin link and not through the thread itself. So far, at least two variations of the message bomb have been identified.
Justify Kentucky Derby Winner and next Triple Crown Winner
Jockey Mike Smith , 52, is also being praised for the successful Derby run, but Smith is directing those praises upward. The Pimlico track is shorter than Churchill Downs, at 9.5 furlongs, down from the 10-furlong track at the Derby.
Weekly LSL Property Services Plc (LON:LSL) Ratings
In a a research report sent to investors on 27 April, Investec stated it was upgrading Hunting PLC (LON:HTG) stock to a "Hold". Peel Hunt reiterated their hold rating on shares of Antofagasta (LON:ANTO) in a research report released on Wednesday morning.
Oil falls after U.S. output hits record
US light crude was 51 cents higher at $68.94, and was on track to gain just over 1 percent on the week. European powers want to hand Mr Trump a plan to save the Iran nuclear deal next week.
White House tree planted by Trump, Macron vanishes
It's also better to plant oak trees in the fall, not the spring, so the gift may very well be back on the lawn in a few months. A pale patch of grass was left in its place. "It will soon be replanted in the White House gardens", the source said.